Financials
- Market Capitalization 16.52 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.werewolftx.com
- Headquarter Delaware, United States
- FIGI BBG00QXQ9XK4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.48
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4659 | KALA KALA BIO, Inc. - Common Stock | 0.96 USD | -11.93% | -36.42% | -64.18% | -82.70% | 17.85 M USD | ||
| 4677 | CYCN Cyclerion Therapeutics, Inc. - Common Stock | 3.83 USD | -1.29% | +15.02% | +21.59% | +20.44% | 16.59 M USD | ||
| 4689 | KTTA Pasithea Therapeutics Corp. - Common Stock | 0.48 USD | -2.04% | -7.69% | -11.11% | -27.27% | 16.04 M USD | ||
| 4694 | QNCX Quince Therapeutics, Inc. - Common Stock | 19.29 USD | +11.83% | +8.74% | +1996.74% | +1015.03% | 15.72 M USD |